PCVX
PCVX
NASDAQ · Biotechnology

Vaxcyte Inc

$55.91
+1.24 (+2.27%)
As of Mar 25, 9:47 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target +20.0% upside
Low Target $56.09
Average Target $67.08
High Target $108.72
Current Price $55.91
Current
$55.91
Target
$67.08
$56.09 $67.08 avg $108.72
Scenario Analysis
Bear Case
$56.09
0.3%
Low target
Base Case
$67.08
+20.0%
Avg target
Bull Case
$108.72
+94.5%
High target
Risk/Reward
293.4x
Highly favorable
Price in Context
52-Week High
$76.61
-27.0% from high
52-Week Low
$27.66
+102.1% from low
50-Day SMA
$49.46
+13.0% vs SMA
200-Day SMA
$39.88
+40.2% vs SMA
RSI (14)
62.6
Neutral
Target vs 52W High
$67.08
-12.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%